Codon 54 polymorphism of the fatty acid binding protein gene and insulin resistance in the Japanese population

Diabetic Medicine

Volumn 16, Issue 2, 1999, Pages 119-124

  Ito, Kuninobu ^a   Nakatani, K ^a   Fujii, M ^a   Katsuki, A ^a   Tsuchihashi, K ^a   Murata, K ^a   Goto, H ^a   Yano, Y ^a   Gabazza, E C ^a   Sumida, Y ^a   Adachi, Y ^a  

^a MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Fatty acid binding protein; Gene polymorphism; Insulin resistance; Japanese population; Type 2 diabetes mellitus

Indexed keywords

ADULT; AGED; ARTICLE; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; HUMAN; INSULIN RESISTANCE; JAPAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE;

CARRIER PROTEINS; CASE-CONTROL STUDIES; CODON; FATTY ACID-BINDING PROTEINS; FEMALE; HUMANS; INSULIN RESISTANCE; INTESTINES; JAPAN; MALE; MIDDLE AGED; MYELIN P2 PROTEIN; NEOPLASM PROTEINS; POLYMORPHISM, GENETIC; TUMOR SUPPRESSOR PROTEINS;

EID: 0032757840     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-5491.1999.00034.x     Document Type: Article

References (38)

1. 1 Lilliojha S, Mott DM, Spraul M, Ferraro R, Foley JE, Ravussin E et al. Insulin resistance and insulin secretory dysfunction as precursor of non-insulin-dependent diabetes mellitus: prospective studies of Pima Indians. N Engl J Med 1993; 329: 1988-1992.
2. 2 Martin B, Warram JH, Krolewski AS, Bergman RN, Soeldner JS, Kahn CR. Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study. Lancet 1992; 340: 925-929.
3. 3 Saad MF, Knowler WC, Pettitt DJ, Nelson RG, Charles MA, Bennett PH. A two-step model for development of non-insulin-dependent diabetes. Am J Med 1991; 90: 229-235.
4. 4 Warram JH, Martin BC, Krolewski AS, Soeldner JS, Kahn CR. Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic parents. Ann Int Med 1990; 113: 909-915.
5. 5 Lillioja S, Mott DM, Zawadzki JK, Young AA, Abbott WG, Knowler WC et al. In vivo insulin action is familial characteristic in nondiabetic Pima Indians. Diabetes 1987; 36: 1329-1335.
6. 6 Barnett AH, Eff C, Leslie RDG, Pyke DA. Diabetes in identical twins: a study of 200 pairs. Diabetologia 1981; 20: 87-94.
7. 7 Hardin D, Maianu L, Sorbel J. Genetic factors are more important than environment in determining insulin sensitivity, muscle GLUT4 content, and related metabolic factors in normal twins (Abstract). Diabetes 1994; 43 (Suppl 1): 73A.
8. 8 Schumacher MC, Hasstedt SJ, Hunt SC, Williams RR, Elbein SC. Major gene effect for insulin levels in familial NIDDM pedigrees. Diabetes 1992; 41: 416-423.
9. 9 Mitchell BD, Kammerer CM, Hixson JE, Atwood LD, Hackleman AS, Blangero JB et al. Evidence for a major gene affecting postchallenge insulin levels in Mexican-Americans. Diabetes 1995; 44: 284-289.
10. 10 Newman B, Selby JV, King MC, Slemenda C, Fabsitz R, Friedman GD. Concordance for type 2 (non-insulin-dependent) diabetes mellitus in male twins. Diabetologia 1987; 30: 763-768.
11. 11 Bogardus C, Lillioja S, Nyomba BL, Zurlo F, Swinburn B, Puente AE et al. Distribution of in vivo insulin action in Pima Indians as mixture of three normal distributions. Diabetes 1989; 38: 1423-1432.
12. 12 Bogardus C, Lillioja S, Ward R, Degregorio M, Mott DM, Ferraro R et al. Association and linkage between insulin resistance and MNS red cell antigens in Pima Indians (Abstract). Diabetes 1991; 40 (Suppl. 1): 297A.
13. 13 Prochazka M, Lillioja S, Tait JF, Knowler WC, Mott DM, Spraul M et al. Linkage of chromosomal markers on 4q with a putative gene determining maximal insulin action in Pima Indians. Diabetes 1993; 42: 514-519.
14. 14 Mitchell BD, Kammerer CM, O'Connell P, Harrison CR, Manire M, Shipman P et al. Evidence for linkage of postchallenge insulin levels with intestinal fatty acid-binding protein (FABP2) in Mexican-Americans. Diabetes 1995; 44: 1046-1053.
15. 15 Humphreys P, McCarthy M, Tuomilehto J, Tuomilehto-Wolf E, Stratton I, Morgan R et al. Chromosome 4q locus associated with insulin resistance in Pima Indians: studies in three European NIDDM populations. Diabetes 1994; 43: 800-804.
16. 16 Elbein SC, Chiu KC, Hoffman MD, Mayorga RA, Bragg KL, Leppert MF. Linkage analysis of 19 candidate regions for insulin resistance in familial NIDDM. Diabetes 1995; 44: 1259-1265.
17. 17 Baier LJ, Sacchettini JC, Knowler WC, Eads J, Paolisso G, Tataranni PA et al. An amino acid substitution in the human intestinal fatty acid binding protein is associated with increased fatty acid binding, increased fat oxidation, and insulin resistance. J Clin Invest 1995; 94: 1281-1287.
18. 18 Randle PJ, Garland PB, Hales CN, Newsholme EA. The glucose fatty-acid cycle: its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1963; i: 785-789.
19. 19 Kadowaki T, Miyake Y, Hagura R, Akanuma Y, Kajinuma H, Kuzuya N et al. Risk factors for worsening to diabetes in subjects with impaired glucose tolerance. Diabetologia 1984; 26: 44-49.
20. 20 Kosaka K, Hagura R, Kuzuya T. Insulin responses in equivocal and definite diabetes, with special reference to subjects who had mild glucose intolerance but later developed definite diabetes. Diabetes 1977; 26: 944-952.
21. 21 Chen KW, Morris LN, Boyko EJ, Wahl PW, Bergstrom RW, Fujimoto WY et al. Earlier appearance of impaired insulin secretion than of visceral adiposity in the pathogenesis of NIDDM: 5-year follow-up of initially nondiabetic Japanese-American men. Diabetes Care 1995; 18: 747-753.
22. 22 Harano Y, Ohgaku S, Kosugi K, Yasuda H, Nakano T, Kobayashi M et al. Clinical significance of altered insulin sensitivity in diabetes mellitus assessed by glucose, insulin, and somatostatin infusion. J Clin Endocrinol Metab 1981; 52: 982-987.
23. 23 Yamada K, Yuan X, Ishiyama S, Koyama K, Ichikawa F, Koyanagi A et al. Association between Ala54Thr substitution of the fatty acid binding protein 2 gene with insulin resistance and intra-abdominal fat thickness in Japanese men. Diabetologia 1997; 40: 706-710.
24. 24 WHO Expert Committee on Diabetes Mellitus. Diabetes Mellitus: Second Report. Technical Report Series 646. Geneva: WHO, 1980.
25. 25 Fujioka S, Matsuzawa Y, Tokunaga K, Tarui S. Contribution of intra-abdominal fat accumulation to the impairment of glucose and lipid metabolism in human obesity. Metabolism 1987; 36: 54-59.
26. 26 DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979; 237: E214-E223.
27. 27 Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
28. 28 Inoue S. Epidemiological study of obesity. In: Annual report o the Japanese Society of Obesity and the Ministry of Health and Welfare of Japan, 1995 (in Japanese).
29. 29 Tarui S. Visceral fat obesity. J Japan Soc Int Med 1993; 82: 1547-1553 (in Japanese).
30. 30 Tokunaga K, Matsuzawa Y, Ishikawa K, Tarui S. A novel technique for the determination of body fat by computed tomography. Int J Obes 1983; 7: 437-445.
31. 31 Sacchettini JC, Gordon JI. Rat intestinal fatty acid binding protein: a model system for analyzing forces that can bind fatty acids to proteins. J Biol Chem 1993; 268: 18399-18402.
32. 32 Sweetser DA, Birkenmeier EH, Klisak IJ, Zollman S, Sparkes RS, Mohandas T et al. The human and rodent intestinal fatty acid binding protein genes: a comparative analysis of their structure, expression, and linkage relationships. J Biol Chem 1987; 262: 16060-16071.
33. 33 Felber JP, Haesler E, Jéuier E. Metabolic origin of insulin resistance in obesity with and without type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1993; 36: 1221-1229.
34. 34 Paolisso G, Tataranni PA, Foley JE, Bogardus C, Howard BV, Ravussin E. A high concentration of fasting plasma non-esterified fatty acids is a risk factor for the development of NIDDM. Diabetologia 1995; 38: 1213-1217.
35. 35 Boden G, Chen X, Rui J, White JV, Rosetti L. Mechanisms of fatty acid-induced inhibition of glucose uptake. J Clin Invest 1994; 93: 2438-2446.
36. 36 Ebeling P, Koivisto VA. Non-esterified fatty acids regulates lipid and glucose oxidation and glycogen synthesis in healthy man. Diabetologia 1994; 37: 202-209.
37. 37 Stedberg J, Bjöntrop P, Smith U, Lönroth P. Effect of free fatty acids on insulin receptor binding and tyrosine kinase activity in hepatocytes isolated from lean and obese rats. Diabetes 1992; 41: 294-298.
38. 38 Fujimoto WY, Leonetti DL, Kinyoun JL, Newell-Morris L, Whuman WP, Stolov WC et al. Prevalence of diabetes mellitus and impaired glucose tolerance among second-generation Japanese-American men. Diabetes 1987; 36: 721-729.